D930

DRUG2 trials

Sponsors

Chong Kun Dang Pharmaceutical

Conditions

GlaucomaOcular HypertensionPrimary Open-angle Glaucoma

Phase 1

Study to Evaluate Drug-drug Interaction, Safety and Tolerability in Case of the Co-administration of D565 and D930

CompletedNCT05207761

Chong Kun Dang PharmaceuticalGlaucoma

Start: 2022-01-19End: 2022-11-02Updated: 2023-01-05

Phase 3

A Clinical Study to Evaluate the Efficacy and Safety of CKD-351

Chong Kun Dang PharmaceuticalOcular Hypertension, Primary Open-angle Glaucoma

Start: 2018-12-07End: 2022-05-30Target: 384Updated: 2018-12-03